Eslamifar Ali, Ramezani Amitis, Ehteram Hassan, Razeghi Effat, Ahmadi Farrokhlagha, Amini Manouchehr, Banifazl Mohammad, Etemadi Gelavizh, Keyvani Hossein, Bavand Anahita, Aghakhani Arezoo
Clinical Research Department, Pasteur Institute of Iran, Tehran, Iran.
Department of Pathology, Faculty of Medicine, Kashan University of Medical Sciences, Kashan, Iran.
J Nephropathol. 2015 Oct;4(4):116-20. doi: 10.12860/jnp.2015.22. Epub 2015 Oct 1.
Occult hepatitis C virus (HCV) infection is defined as the presence of HCV-RNA in liver or peripheral blood mononuclear cells (PBMCs) in the absence of detectable hepatitis C antibody (anti-HCV) or HCV-RNA in the serum. Low concentrations of HCV-RNA may be detected in PBMCs of hemodialysis (HD) patients and this could have a great impact on the management of HD patients.
The aim of this study was to detect the occult HCV infection in Iranian HD patients.
A total of 70 anti-HCV negative HD patients from three dialysis units in Tehran, Iran were included in this study. In these cases, presence of HCV-RNA in plasma samples was tested by reverse transcriptase-nested polymerase chain reaction (RT-nested PCR). In cases with negative anti-HCV and plasma HCV-RNA, genomic HCV-RNA was checked in PBMC specimens by RT-nested PCR.
Seventy anti-HCV negative HD patients were enrolled in the study. 32.85% and 1.43% of cases had elevated levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) respectively. 7.14% of patients had elevated levels of both ALT and AST. HCV-RNA was negative in plasma samples of all anti-HCV negative HD subjects. The genomic HCV-RNA was not detected in any PBMC samples of HD cases with negative anti-HCV and plasma HCV-RNA.
Occult HCV infection was not detected in our HD patients despite of elevated levels of liver enzymes in some participants. Further studies involving larger number of HD patients are required to elucidate the rate of occult HCV infection in HD cases.
隐匿性丙型肝炎病毒(HCV)感染的定义为,在血清中检测不到丙型肝炎抗体(抗-HCV)或HCV-RNA的情况下,肝脏或外周血单核细胞(PBMC)中存在HCV-RNA。血液透析(HD)患者的PBMC中可能检测到低浓度的HCV-RNA,这可能对HD患者的管理产生重大影响。
本研究旨在检测伊朗HD患者中的隐匿性HCV感染。
本研究纳入了来自伊朗德黑兰三个透析单元的70例抗-HCV阴性的HD患者。对这些患者,采用逆转录巢式聚合酶链反应(RT-巢式PCR)检测血浆样本中HCV-RNA的存在情况。对于抗-HCV和血浆HCV-RNA均为阴性的病例,通过RT-巢式PCR检测PBMC标本中的基因组HCV-RNA。
70例抗-HCV阴性的HD患者纳入研究。分别有32.85%和1.43%的病例丙氨酸氨基转移酶(ALT)和天冬氨酸氨基转移酶(AST)水平升高。7.14%的患者ALT和AST水平均升高。所有抗-HCV阴性的HD受试者血浆样本中HCV-RNA均为阴性。在抗-HCV和血浆HCV-RNA均为阴性的HD病例的任何PBMC样本中均未检测到基因组HCV-RNA。
尽管部分参与者肝酶水平升高,但我们的HD患者中未检测到隐匿性HCV感染。需要开展涉及更多HD患者的进一步研究,以阐明HD病例中隐匿性HCV感染的发生率。